![Blood Advances(@BloodAdvances) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Blood Advances
@BloodAdvances
Blood Advances, a digital open-access journal from the American Society of Hematology, @ASH_hematology
ID:732570175162179585
http://www.bloodadvances.org 17-05-2016 13:55:15
6,2K Tweets
31,9K Followers
138 Following
Follow People
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Steroid tapering after GVHD Rx: not too fast, not too slow
ow.ly/nUUb50Rmrgt #InsideBloodAdvances #IBAs #transplantation
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-25 17:01:19 Steroid tapering after GVHD Rx: not too fast, not too slow ow.ly/nUUb50Rmrgt #InsideBloodAdvances #IBAs #transplantation Steroid tapering after GVHD Rx: not too fast, not too slow ow.ly/nUUb50Rmrgt #InsideBloodAdvances #IBAs #transplantation](https://pbs.twimg.com/media/GMBp06MWwAAvPdP.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Better eat!
ow.ly/ro2Z50Rmrbu #InsideBloodAdvances #IBAs #hematopoiesisandstemcells #transplantation
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Survival for the fittest: guadecitabine in rel/ref AML
ow.ly/JRbc50Rmr6f #InsideBloodAdvances #IBAs #clinicaltrialsandobservations #myeloidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-25 13:02:03 Survival for the fittest: guadecitabine in rel/ref AML ow.ly/JRbc50Rmr6f #InsideBloodAdvances #IBAs #clinicaltrialsandobservations #myeloidneoplasia Survival for the fittest: guadecitabine in rel/ref AML ow.ly/JRbc50Rmr6f #InsideBloodAdvances #IBAs #clinicaltrialsandobservations #myeloidneoplasia](https://pbs.twimg.com/media/GMAzEISXkAAYEAL.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study
ow.ly/E9WX50Rmr2b #lymphoidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-24 17:01:41 Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study ow.ly/E9WX50Rmr2b #lymphoidneoplasia Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study ow.ly/E9WX50Rmr2b #lymphoidneoplasia](https://pbs.twimg.com/media/GL8gUtZXAAAf9MR.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy
ow.ly/bq3m50RmqWc #immunobiologyandimmunotherapy #lymphoidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-24 15:02:20 Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy ow.ly/bq3m50RmqWc #immunobiologyandimmunotherapy #lymphoidneoplasia Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy ow.ly/bq3m50RmqWc #immunobiologyandimmunotherapy #lymphoidneoplasia](https://pbs.twimg.com/media/GL8FAUeXAAE3p-V.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up
ow.ly/jHSN50RmqRl #clincialtrialsandobservations #myeloidneplasia #transplantation
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-24 13:02:39 Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up ow.ly/jHSN50RmqRl #clincialtrialsandobservations #myeloidneplasia #transplantation Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up ow.ly/jHSN50RmqRl #clincialtrialsandobservations #myeloidneplasia #transplantation](https://pbs.twimg.com/media/GL7pnD4XoAAmArD.jpg)
![ASH(@ASH_hematology) 's Twitter Profile Photo ASH(@ASH_hematology) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1369339394172325897/tL9NtM9Q_200x200.png)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Peripheral blood regulatory T cells associate with teclistamab failure, whereas CD8+ effector T cells associate with teclistamab response. ow.ly/hogy50RbM1J #lymphoidneoplasia #immunobiologyandimmunotherapy
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-22 19:00:33 Peripheral blood regulatory T cells associate with teclistamab failure, whereas CD8+ effector T cells associate with teclistamab response. ow.ly/hogy50RbM1J #lymphoidneoplasia #immunobiologyandimmunotherapy Peripheral blood regulatory T cells associate with teclistamab failure, whereas CD8+ effector T cells associate with teclistamab response. ow.ly/hogy50RbM1J #lymphoidneoplasia #immunobiologyandimmunotherapy](https://pbs.twimg.com/media/GLyoWaCWIAAWkux.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
IPI risk factors are associated with different genetic and tumor microenvironmental signatures in DLBCL. ow.ly/aLwS50RbM5C #lymphoidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-22 17:01:01 IPI risk factors are associated with different genetic and tumor microenvironmental signatures in DLBCL. ow.ly/aLwS50RbM5C #lymphoidneoplasia IPI risk factors are associated with different genetic and tumor microenvironmental signatures in DLBCL. ow.ly/aLwS50RbM5C #lymphoidneoplasia](https://pbs.twimg.com/media/GLyM_bgW4AAR_KG.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Gene-corrected RAG2 locus restores V(D)J recombination in stem cells of patients with RAG2-SCID, promoting TCR and B-cell receptor formation. ow.ly/KL1k50RbLXW #genetherapy #hematopoiesisandstemcells
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-22 15:01:20 Gene-corrected RAG2 locus restores V(D)J recombination in stem cells of patients with RAG2-SCID, promoting TCR and B-cell receptor formation. ow.ly/KL1k50RbLXW #genetherapy #hematopoiesisandstemcells Gene-corrected RAG2 locus restores V(D)J recombination in stem cells of patients with RAG2-SCID, promoting TCR and B-cell receptor formation. ow.ly/KL1k50RbLXW #genetherapy #hematopoiesisandstemcells](https://pbs.twimg.com/media/GLxxmNJXkAAb1WE.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
We present a novel immunotherapy platform for hematological cancers that exploits fundamental metabolic dysregulation of cancer cells. ow.ly/e6ro50RbLTK #immunobiologyandimmunotherapy #myeloidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-22 13:01:36 We present a novel immunotherapy platform for hematological cancers that exploits fundamental metabolic dysregulation of cancer cells. ow.ly/e6ro50RbLTK #immunobiologyandimmunotherapy #myeloidneoplasia We present a novel immunotherapy platform for hematological cancers that exploits fundamental metabolic dysregulation of cancer cells. ow.ly/e6ro50RbLTK #immunobiologyandimmunotherapy #myeloidneoplasia](https://pbs.twimg.com/media/GLxWMVwXIAAT09A.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
There is a strong correlation between the stage and severity of granulocyte development disruption and the efficacy of G-CSF therapy. ow.ly/TYop50RbLJ7 #phagocytesgranulocytesandmyelopoiesis
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-20 14:00:36 There is a strong correlation between the stage and severity of granulocyte development disruption and the efficacy of G-CSF therapy. ow.ly/TYop50RbLJ7 #phagocytesgranulocytesandmyelopoiesis There is a strong correlation between the stage and severity of granulocyte development disruption and the efficacy of G-CSF therapy. ow.ly/TYop50RbLJ7 #phagocytesgranulocytesandmyelopoiesis](https://pbs.twimg.com/media/GLnQg-pXYAAsURw.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Our multivalent, thiol-reactive chemistry covalently links immune adjuvants to free thiols on cancer cell debris induced by chemotherapy. ow.ly/cfwv50RbMrW #immunobiologyandimmunotherapy #myeloidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-19 17:00:55 Our multivalent, thiol-reactive chemistry covalently links immune adjuvants to free thiols on cancer cell debris induced by chemotherapy. ow.ly/cfwv50RbMrW #immunobiologyandimmunotherapy #myeloidneoplasia Our multivalent, thiol-reactive chemistry covalently links immune adjuvants to free thiols on cancer cell debris induced by chemotherapy. ow.ly/cfwv50RbMrW #immunobiologyandimmunotherapy #myeloidneoplasia](https://pbs.twimg.com/media/GLiwMkZWAAEiAcz.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
We propose a new classification of VWD type 2M/2A for p.R1315L, p.R1374H, and p.R1374C because they share a common phenotype with 2M and 2A. ow.ly/Ebqs50RbMIU #thrombosisandhemostasis #vascularbiology
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-19 15:01:04 We propose a new classification of VWD type 2M/2A for p.R1315L, p.R1374H, and p.R1374C because they share a common phenotype with 2M and 2A. ow.ly/Ebqs50RbMIU #thrombosisandhemostasis #vascularbiology We propose a new classification of VWD type 2M/2A for p.R1315L, p.R1374H, and p.R1374C because they share a common phenotype with 2M and 2A. ow.ly/Ebqs50RbMIU #thrombosisandhemostasis #vascularbiology](https://pbs.twimg.com/media/GLiUxKDWcAAkKi9.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
RBC transfusion can restore quiescence in previously activated immune cells under inflammatory conditions, such as sickle cell disease. ow.ly/V8Ac50RbLFu #transfusionmedicine #redcellsironanderythropoiesis #vascularbiology
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-19 13:01:30 RBC transfusion can restore quiescence in previously activated immune cells under inflammatory conditions, such as sickle cell disease. ow.ly/V8Ac50RbLFu #transfusionmedicine #redcellsironanderythropoiesis #vascularbiology RBC transfusion can restore quiescence in previously activated immune cells under inflammatory conditions, such as sickle cell disease. ow.ly/V8Ac50RbLFu #transfusionmedicine #redcellsironanderythropoiesis #vascularbiology](https://pbs.twimg.com/media/GLh5Ze3XEAEApYv.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Among individuals at elevated risk of multiple myeloma, obesity is positively associated with mass spectrometry–detected MGUS. ow.ly/TOPe50RbM0m #lymphoidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-18 19:00:39 Among individuals at elevated risk of multiple myeloma, obesity is positively associated with mass spectrometry–detected MGUS. ow.ly/TOPe50RbM0m #lymphoidneoplasia Among individuals at elevated risk of multiple myeloma, obesity is positively associated with mass spectrometry–detected MGUS. ow.ly/TOPe50RbM0m #lymphoidneoplasia](https://pbs.twimg.com/media/GLeCAv2WwAAxMCj.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Different forms of congenital neutropenia exhibit disruptions in granulocyte development at distinct stages. ow.ly/buMP50RbMyb #phagocytesgranulocytesandmyelopoiesis
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-18 17:00:58 Different forms of congenital neutropenia exhibit disruptions in granulocyte development at distinct stages. ow.ly/buMP50RbMyb #phagocytesgranulocytesandmyelopoiesis Different forms of congenital neutropenia exhibit disruptions in granulocyte development at distinct stages. ow.ly/buMP50RbMyb #phagocytesgranulocytesandmyelopoiesis](https://pbs.twimg.com/media/GLdmnmEWcAAvgpT.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
Understanding differences in RBC survival may inform hemoglobin composition thresholds required to reverse the phenotype after gene therapy. ow.ly/sUzh50RbLtT #clinicaltrialsandobservations #genetherapy #redcellsironanderythropoiesis #transplantation
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-18 15:01:16 Understanding differences in RBC survival may inform hemoglobin composition thresholds required to reverse the phenotype after gene therapy. ow.ly/sUzh50RbLtT #clinicaltrialsandobservations #genetherapy #redcellsironanderythropoiesis #transplantation Understanding differences in RBC survival may inform hemoglobin composition thresholds required to reverse the phenotype after gene therapy. ow.ly/sUzh50RbLtT #clinicaltrialsandobservations #genetherapy #redcellsironanderythropoiesis #transplantation](https://pbs.twimg.com/media/GLdLOGnWgAAmQy7.jpg)
![Blood Advances(@BloodAdvances) 's Twitter Profile Photo Blood Advances(@BloodAdvances) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1355224045554454539/wBxn7pzE_200x200.jpg)
A similar proportion of participants remained on antibiotics at 12 months as those on immunoglobulins, with similar rates of major infection. #clinicaltrialsandobservations #lymphoidneoplasia
![Blood Advances (@BloodAdvances) on Twitter photo 2024-04-18 13:01:10 A similar proportion of participants remained on antibiotics at 12 months as those on immunoglobulins, with similar rates of major infection. #clinicaltrialsandobservations #lymphoidneoplasia A similar proportion of participants remained on antibiotics at 12 months as those on immunoglobulins, with similar rates of major infection. #clinicaltrialsandobservations #lymphoidneoplasia](https://pbs.twimg.com/media/GLcvu9hXAAApsmI.jpg)